Literature DB >> 27628642

Vasopressin receptor antagonists in patients with chronic heart failure.

R De Vecchis1, C Cantatrione2, D Mazzei2.   

Abstract

In this brief review, the pathophysiology of hyponatremia and its clinical significance in the course of chronic heart failure (CHF) are illustrated. Moreover, issues concerning the optimal treatment for hyponatremia during CHF are addressed and discussed. In addition, advantages and limitations resulting from the use of vasopressin receptor antagonists, drugs that have recently emerged as the best available resource against hyponatremia, are highlighted.

Entities:  

Keywords:  Antidiuretic hormone receptor antagonist; Heart failure; Hyponatremia; Hypovolemia; Sodium

Mesh：

Substances：

Year:  2016        PMID： 27628642     DOI： 10.1007/s00059-016-4482-9

Source DB:  PubMed          Journal:  Herz        ISSN： 0340-9937            Impact factor:   1.443


  35 in total

1.  Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.

Authors:  Salvatore Paterna; Pietro Di Pasquale; Gaspare Parrinello; Ersilia Fornaciari; Francesca Di Gaudio; Sergio Fasullo; Marco Giammanco; Filippo M Sarullo; Giuseppe Licata
Journal:  J Am Coll Cardiol       Date:  2005-06-21       Impact factor: 24.094

Review 2.  [Recent advances in the investigation of the renin-angiotensin and cardiac natriuretic systems in patients with chronic heart insufficiency].

Authors:  J F Arnal; P Cudek; P F Plouin; T T Guyenne; J C Dussaule; J B Michel; R Rullière; J Valty; J P Bourdarias; P Corvol
Journal:  Arch Mal Coeur Vaiss       Date:  1991-09

Review 3.  Central pontine myelinolysis.

Authors:  Christian Lampl; Kambiz Yazdi
Journal:  Eur Neurol       Date:  2002       Impact factor: 1.710

Review 4.  Diuretic therapy in heart failure: current controversies and new approaches for fluid removal.

Authors:  Filippo Brandimarte; Gian Francesco Mureddu; Alessandro Boccanelli; Giuseppe Cacciatore; Camillo Brandimarte; Francesco Fedele; Mihai Gheorghiade
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2010-08       Impact factor: 2.160

5.  Awareness and management of hyponatraemia: the Italian Hyponatraemia Survey.

Authors:  C Giuliani; M Cangioli; P Beck-Peccoz; M Faustini-Fustini; E Fiaccadori; A Peri
Journal:  J Endocrinol Invest       Date:  2013-04-02       Impact factor: 4.256

Review 6.  Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods.

Authors:  Baha M Arafah
Journal:  J Clin Endocrinol Metab       Date:  2006-08-01       Impact factor: 5.958

7.  Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry.

Authors:  Mihai Gheorghiade; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Barry H Greenberg; Christopher M O'Connor; Lilin She; Clyde W Yancy; James Young; Gregg C Fonarow
Journal:  Eur Heart J       Date:  2007-02-19       Impact factor: 29.983

Review 8.  Decreased effective blood volume in edematous disorders: what does this mean?

Authors:  Robert W Schrier
Journal:  J Am Soc Nephrol       Date:  2007-06-13       Impact factor: 10.121

Review 9.  Clinical review: the use of vaptans in clinical endocrinology.

Authors:  Alessandro Peri
Journal:  J Clin Endocrinol Metab       Date:  2013-02-11       Impact factor: 5.958

10.  A metabolic study of patients with lung cancer and hyponatremia of malignancy.

Authors:  John P Chute; Elizabeth Taylor; John Williams; Frederic Kaye; David Venzon; Bruce E Johnson
Journal:  Clin Cancer Res       Date:  2006-02-01       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.